NCT05053867View on ClinicalTrials.gov

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

PHASE3RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

October 14, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Pulmonary HemorrhageCancer

Interventions

DRUG

tranexamic acid

Inhaled

OTHER

Usual Care

Standard of Care

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER